Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Non-Hodgkin 9Congenital Abnormalities 9Myelodysplastic Syndromes 7Multiple Myeloma 7Lymphoma, Mantle-Cell 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 6Hodgkin Disease 6Myeloproliferative Disorders 5Leukemia, Myeloid, Accelerated Phase 5Waldenstrom Macroglobulinemia 4Sezary Syndrome 4Recurrence 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Follicular 4Lymphoma, Extranodal NK-T-Cell 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Graft vs Host Disease 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myelomonocytic, Juvenile 3Intraocular Lymphoma 3Immunoblastic Lymphadenopathy 3

Interventions

Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × High Risk Hematologic Malignancy × Transplantation × Clear all
NCT03913026 2025-10-27

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

Ciusss de L'Est de l'Île de Montréal

Phase 2 Active not recruiting
30 enrolled

High Risk Hematologic Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡